Henke K, Hartmann G H, Peschke P, Hahn E W
German Cancer Research Center, Department of Radiology, Heidelberg, Germany.
Int J Radiat Oncol Biol Phys. 1996 Sep 1;36(2):385-91. doi: 10.1016/s0360-3016(96)00266-0.
Stereotactic radiosurgery (RS) is being used increasingly for the treatment of small benign and malignant lesions, particularly in the brain. However, to fully realize the potential of this technique, more experimental data are needed. In this report we describe an RS technique suitable for small animals, and present the results obtained with different irradiation doses and volumes given to a rat prostate tumor.
Single doses of RS were administered to the Dunning prostate R3327-AT1 carcinoma transplanted subcutaneously into the thigh of male Copenhagen rats. The tumors (approximately 5 mm in diameter) were localized within a stereotactic frame and irradiated at a linac facility (15 MV) with single doses of 15.3, 30.6, 46.0, 61.3, or 76.6 Gy at the 80% isodose level using narrow beams from 3- and 5-mm collimators (80% isodose field size of 5 or 8.5 mm, respectively) and a six-arc irradiation technique. Tumor size was measured three times a week (Mondays, Wednesdays, and Fridays). Conventional stains were used to examine the histologic status of the tumors. To evaluate the proliferative response of the tumors to RS and assess the prevalence and spatial distribution of proliferating cells, tissue slices were stained with the proliferation markers 5-bromo-2'- deoxyuridine and proliferating cell nuclear antigen 4 and 8 h, and 4, 8, 12, and 210 days after stereotactic irradiation with a dose of 61.3 Gy.
The extent of growth delay and local tumor control depended on the radiation dose, the field size, and the accuracy of irradiation. Local control at day 100 ranged from two of eight rats at 30.6 Gy, five of seven rats at 61.3 Gy, and six of seven at 76.6 Gy. No overt side effects in the surrounding tissues was observed. After 61.3 Gy, the immunohistochemical staining revealed a rapid decrease of proliferative active tumor cells after irradiation. The irradiated tumor tissue was gradually replaced by connective tissue. However, in one persistent nodule, a few proliferative cells were detected even after 200 days.
A radiosurgical technique was successfully developed for a small animal system. The technique was concluded to be reproducible and suitable for future use in single and fractionated treatment regimens.
立体定向放射外科(RS)越来越多地用于治疗小型良性和恶性病变,尤其是脑部病变。然而,为了充分发挥该技术的潜力,还需要更多的实验数据。在本报告中,我们描述了一种适用于小动物的RS技术,并展示了给予大鼠前列腺肿瘤不同照射剂量和体积后所获得的结果。
对皮下移植到雄性哥本哈根大鼠大腿的邓宁前列腺R3327 - AT1癌给予单次RS剂量。将肿瘤(直径约5毫米)置于立体定向框架内,在直线加速器设备(15 MV)上,使用来自3毫米和5毫米准直器的窄束(80%等剂量场大小分别为5或8.5毫米)和六弧照射技术,在80%等剂量水平给予15.3、30.6、46.0、61.3或76.6 Gy的单次剂量照射。每周三次(周一、周三和周五)测量肿瘤大小。使用传统染色检查肿瘤的组织学状态。为了评估肿瘤对RS的增殖反应并评估增殖细胞的发生率和空间分布,在立体定向照射61.3 Gy后的4和8小时、4、8、12和210天,用增殖标记物5 - 溴 - 2'-脱氧尿苷和增殖细胞核抗原对组织切片进行染色。
生长延迟程度和局部肿瘤控制取决于辐射剂量、照射野大小和照射精度。100天时的局部控制情况为:30.6 Gy组8只大鼠中有2只,61.3 Gy组7只大鼠中有5只,76.6 Gy组7只大鼠中有6只。未观察到周围组织有明显副作用。61.3 Gy照射后,免疫组织化学染色显示照射后增殖活跃的肿瘤细胞迅速减少。照射后的肿瘤组织逐渐被结缔组织取代。然而,在一个持续存在的结节中,即使在200天后仍检测到少数增殖细胞。
成功开发了一种适用于小动物系统的放射外科技术。该技术被认为具有可重复性,适用于未来的单次和分次治疗方案。